Učitavanje...
SNW1 is a prognostic biomarker in prostate cancer
BACKGROUND: SNW1 is a nuclear receptor co-activator involved in splicing and transcription control, including androgen receptor signaling. Overexpression of SNW1 has been linked to adverse prognosis in different cancer types, but studies on the role of SNW1 in prostate cancer are lacking. METHODS: U...
Spremljeno u:
| Izdano u: | Diagn Pathol |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495565/ https://ncbi.nlm.nih.gov/pubmed/31043167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-019-0810-8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|